BSE Grants Listing Approval to Nexome Capital Markets for 19,20,000 Preferential Equity Shares
BSE Limited granted listing approval on May 07, 2026, to Nexome Capital Markets Limited for 19,20,000 equity shares of Rs. 10/- each, issued at a premium of Rs. 54/- per share on a preferential basis via warrant conversion. The shares, bearing distinctive numbers from 88,15,501 to 1,07,35,500, were allotted to both Promoter and Non-Promoter categories. Trading approval remains contingent on the company submitting requisite confirmations from NSDL/CDSL and, if applicable, a listing approval from NSE. The company must also apply for trading approval within seven working days of the listing approval date, as per SEBI's circular dated June 21, 2023.

*this image is generated using AI for illustrative purposes only.
Nexome Capital Markets Limited (formerly SMIFS Capital Markets Limited) has received listing approval from BSE Limited for 19,20,000 equity shares issued on a preferential basis through the conversion of warrants. The approval, communicated via BSE reference LOD/PREF/GB/FIP/195/2026-27 dated May 07, 2026, marks a significant step in the company's capital restructuring exercise under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Details of the Preferential Allotment
The newly listed shares carry a face value of Rs. 10/- each and were issued at a premium of Rs. 54/- per share. The allotment covers both Promoter and Non-Promoter categories, with the shares assigned distinctive numbers from 88,15,501 to 1,07,35,500. The table below summarises the key parameters of this preferential issue:
| Parameter: | Details |
|---|---|
| Number of Shares: | 19,20,000 equity shares |
| Face Value: | Rs. 10/- per share |
| Issue Premium: | Rs. 54/- per share |
| Distinctive Numbers: | 88,15,501 to 1,07,35,500 |
| Allottee Category: | Promoter and Non-Promoters |
| Basis of Issue: | Preferential allotment via warrant conversion |
| BSE Approval Reference: | LOD/PREF/GB/FIP/195/2026-27 |
| Date of Approval: | May 07, 2026 |
Regulatory Compliance Requirements
BSE has outlined several conditions that Nexome Capital Markets must fulfil before trading approval is granted for these shares. The exchange has directed the company to ensure compliance with Regulation 167 of SEBI (ICDR) Regulations and any subsequent SEBI directives. Additionally, in the event of a change exceeding two per cent of the total paid-up share capital, the company is required to file the shareholding pattern in XBRL mode as mandated under Regulation 31(1)(c) of SEBI LODR Regulations, 2015.
Conditions Precedent to Trading Approval
Trading approval for the aforementioned shares will be granted only upon the company submitting the following to BSE:
- Listing approval from the National Stock Exchange of India Ltd. (if applicable)
- Confirmation letters from NSDL/CDSL confirming the crediting of shares to respective beneficiary accounts or admission of capital to the depository system
- Confirmation letters from NSDL/CDSL regarding lock-in of pre-preferential holding (if applicable)
Further, as per Schedule XIX of ICDR Regulations and SEBI circular no. SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023, Nexome Capital Markets is required to apply for trading approval to the stock exchange(s) within seven working days from the date of grant of listing approval. Non-compliance with this requirement will attract fines as specified in the said SEBI circular.
Company Communication
The disclosure was filed by Sanjana Gupta, Company Secretary cum Compliance Officer of Nexome Capital Markets Limited, in accordance with Regulation 30 of SEBI (LODR) Regulations, 2015. The BSE listing approval letter was issued by Marian D'souza, Assistant Vice President, and Gaurav Bajare, Deputy Manager, on behalf of BSE Limited. The company is headquartered at Vaibhav, 4th Floor, 4 Lee Road, Kolkata, West Bengal – 700020.
Historical Stock Returns for Nexome Capital Markets
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +3.89% | +4.52% | +26.61% | -7.56% | +36.14% | +234.08% |
How will the addition of 19,20,000 new equity shares impact Nexome Capital Markets' promoter shareholding pattern and potential dilution for existing shareholders?
What strategic initiatives or business expansion plans is Nexome Capital Markets likely to fund using the capital raised through this preferential allotment?
Will Nexome Capital Markets seek trading approval from the National Stock Exchange (NSE) in addition to BSE, and how might dual-listing affect the stock's liquidity?


































